CD44 and breast carcinoma: Further investigation indicates that these breast cancer tumors contain a subpopulation of highly tumorigenic cancer stem cells (CSCs) characterized by high CD44 expression and low (or no) CD24 expression (CD44+CD24−/low) [28,29].